Is Avenue Therapeutics, Inc. (ATXI) a Buy, Sell, or Hold?
OTC : ATXI
Avenue Therapeutics, Inc. — Institutional Ownership
$0.2551 USD
$0 (0.0%)
- Volume
- 10
- Average Volume
- 3.24K
- Market Capitalization
- $840.55K
- P/E Ratio
- -0.30
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $0.97
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.38
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-02-17 | Ikarian Capital, LLC | 130.82K | 4.10% |
| 2026-01-06 | Fortress Biotech, Inc. | 439.96K | 13.40% |
| 2025-04-02 | Fortress Biotech, Inc. | 328.75K | 10.30% |
| 2025-02-14 | Ikarian Capital, LLC | 140K | 6.80% |
| 2025-02-14 | Armistice Capital, LLC | 100.4K | 4.99% |
| 2025-01-03 | Fortress Biotech, Inc. | 295.02K | 13.80% |
| 2024-11-14 | Steven Boyd | 115K | 7.21% |
| 2024-11-14 | Armistice Capital, LLC | 115K | 7.21% |
| 2023-11-28 | Robert Davidow | 1.93M | 14.50% |
| 2022-10-19 | INVAGEN PHARMACEUTICALS INC. 20-1420845 | - | 0.00% |
| 2022-10-19 | CIPLA LIMITED | - | 0.00% |
| 2022-10-19 | CIPLA (EU) LIMITED | - | 0.00% |
| 2022-10-17 | CVI Investments, Inc. | 272.7K | 6.60% |
| 2022-10-17 | Intracoastal Capital LLC | 216.79K | 4.99% |
| 2022-10-17 | Heights Capital Management, Inc. | 272.7K | 6.60% |
| 2022-10-17 | Daniel B. Asher | 216.79K | 4.99% |
| 2022-10-17 | Mitchell P. Kopin | 216.79K | 4.99% |
| 2022-02-14 | Daniel Mack | 1.45M | 7.70% |
| 2022-02-14 | Nantahala Capital Management, LLC | 1.45M | 7.70% |
| 2022-02-14 | Wilmot B. Harkey | 1.45M | 7.70% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 452.65K | 2.42% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 452.65K | 2.42% |
| 2022-02-09 | Vanguard Index Funds - Vanguard Total Stock Market Index Fund - 23-2671505 | 314.4K | 1.68% |
| 2022-02-09 | Vanguard Index Funds - Vanguard Total Stock Market Index Fund - 23-2671505 | 314.4K | 1.68% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 939.71K | 5.61% |
| 2021-02-08 | VANGUARD INDEX FUNDS - VANGUARD TOTAL STOCK MARKET INDEX FUND - 23-2671505 | 838.83K | 5.01% |
| 2019-01-22 | 1 | 9.0 | 11.00% |
| 2019-01-22 | 1 | 9.0 | 11.00% |
| 2017-10-19 | Fortress Biotech, Inc. 20-5157386 | 3.57M | 33.10% |
ATXI Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.68 | 3.13M | $2.13M | $2.86M | -$ | -$725.2K |
| 2024-12-31 | $2.00 | 12.95M | $25.9M | $2.59M | -$ | $23.31M |
| 2023-12-31 | $905.63 | 141K | $127.69M | $1.78M | -$ | $125.91M |
| 2022-12-31 | $6525.03 | 29135 | $190.11M | $6.71M | -$ | $183.4M |
| 2021-12-31 | $1149193.63 | 1.13M | $1.3T | $3.76M | -$ | $1.3T |
| 2020-12-31 | $7530508.91 | 1.1M | $8.28T | $3.13M | -$ | $8.28T |
| 2019-12-31 | $12150064.00 | 1.05M | $12.73T | $8.74M | -$ | $12.73T |
| 2018-12-31 | $6834411.45 | 682.61K | $4.67T | $2.67M | -$ | $4.67T |
| 2017-12-31 | $4581586.93 | 442.33K | $2.03T | $11.78M | -$ | $2.03T |
| 2016-12-31 | $10441461.00 | 589.43K | $6.15T | $197K | $5.87M | $6.15T |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.28 | 3.29M | $922.59K | $1.94M | -$ | -$1.02M |
| 2026-03-31 | $0.29 | 3.29M | $955.18K | $2.42M | -$ | -$1.46M |
| 2025-12-31 | $0.68 | 3.13M | $2.13M | $2.86M | -$ | -$725.2K |
| 2025-09-30 | $0.79 | 3.18M | $2.51M | $3.71M | -$ | -$1.2M |
| 2025-06-30 | $0.20 | 3.18M | $638.94K | $3.33M | -$ | -$2.69M |
| 2025-03-31 | $0.30 | 2.97M | $891.3K | $3.5M | -$ | -$2.61M |
| 2024-12-31 | $2.00 | 1.6M | $3.2M | $2.59M | -$ | $606K |
| 2024-09-30 | $2.49 | 1.6M | $3.98M | $2.6M | -$ | $1.39M |
| 2024-06-30 | $3.40 | 1.12M | $3.8M | $4.92M | -$ | -$1.12M |
| 2024-03-31 | $844.32 | 562.04K | $474.55M | $3.19M | -$ | $471.35M |
| 2023-12-31 | $905.63 | 25.6M | $23.18B | $1.78M | -$ | $23.18B |
| 2023-09-30 | $3976.90 | 8.11M | $32.27B | $161K | -$ | $32.27B |